Trisha is a State of Washington native who joined Knudra in 2010 as a Harvard-trained postdoc. Trisha’s skill set was developed from over 10 years working in genetics, RNAi and qPCR techniques. As a result, her capacity is making profound impact on the efficiencies in transgenesis projects. In business, Trisha’s recent graduation from the exclusive Goldman Sachs 10,000 Small Business mentoring program is being leveraged to improve client experience and achieve greater profitability. As Chief Executive Officer, Trisha brings balance guidance to lead the performance from the business and production teams. Under Trisha’s leadership, Knudra has reached solvency needed for future sustainability of Knudra’s TavaServ platform of services.
Chris founded Knudra in 2009 to commercialize MosSCI transgenesis technology. As a postdoc in the lab of Dr. Erik Jorgensen, Chris has the good fortune to witness and make contributions to the development of the MosSCI transgenesis technique, which was lead by Dr. Christian Frøkjær-Jensen. Chris realized that the art of genome engineering was being commercially served to mice and flies, yet no commercial firm was offering transgenesis service to the worm community. Seizing on the opportunity with receipt of a SBIR contract from the National Institute of Health, Chris pioneered converting the contract work of making nematodes biosensors for the NIEHS into a general service platform to provide custom transgenics to biomedical researchers worldwide. Chris recently obtained a MBA from Westminster College. Chris uses his MBA knowledge to expand marketing and create sales in the broader market of model-organism genome engineering.